IRADIMED CORPORATION Announces Board Transition: Anthony Vuoto Retires, Joe Kiani Appointed as New Director

Core Viewpoint - Iradimed Corporation announced a transition in its Board of Directors, with Anthony Vuoto retiring and Joe Kiani appointed as his successor, effective September 2, 2025. This change is expected to enhance the company's strategic direction in the medical device sector, particularly in MRI-compatible technologies [1][4]. Group 1: Board Transition - Anthony Vuoto has retired from his position as a director after serving since 2016, contributing significantly to the company's growth and innovation [2]. - Joe Kiani, founder of Masimo Corporation and a recognized innovator in medical technology, has been appointed to the Board, bringing extensive experience and over 500 patents [3][4]. Group 2: Company Overview - Iradimed Corporation specializes in developing innovative MRI-compatible medical devices, including patient monitoring and infusion systems [5]. - The company is the only known provider of a non-magnetic intravenous infusion pump system designed for safe use during MRI procedures, addressing safety concerns associated with standard infusion pumps [6]. - The Iradimed 3880 MRI-compatible patient vital signs monitoring system is designed to operate in magnetic fields up to 30,000 gauss, ensuring continuous monitoring of critically ill patients during MRI scans [7].